logo

Before The Bell

Share SHARE

Modine Manufacturing Co. (MOD) reported fourth quarter EPS of $0.35 after the close Wednesday, compared to $0.36 last year. Street expectations were for EPS of $0.34. Modine Manufacturing gapped open higher Thursday and climbed during the first 45 minutes of trade. The stock was range-bound for the...

International Game Technology (IGT) reported first quarter EPS of $0.29 Thursday morning, down from $0.57 a year ago. Analysts expected EPS of $0.48. International Game Technology gapped open lower Thursday and spiked to the downside in early trade. Shares finished with a loss of 2.75 at $18.25 on...

Genesco Inc. (GCO) reported first quarter EPS of $0.06 Thursday morning, down from $0.62 in the previous year. The company now expects to report full year 2018 adjusted EPS of $3.90 to $4.05, compared to prior guidance of $4.40 to $4.55. Genesco gapped open sharply lower Thursday and sank further...

PVH Corp. (PVH) reported first quarter EPS of $1.65 after the bell Wednesday, up from $1.50 in the previous year. The consensus estimate was for EPS of $1.60. PVH gapped open sharply higher Thursday, but moved in a narrow range throughout the session. The stock closed up by 4.94 at $106.98 on above...

Biocryst Pharmaceuticals Inc. (BCRX) announced positive results from the second interim analysis of its APeX-1 trial Thursday morning. Biocryst Pharmaceuticals gapped up sharply Thursday and climbed in early trade, but settled into a range for the majority of the day. Shares finished with a gain of...

Piper Jaffray reiterated its "Overweight" rating on shares of Netflix Inc. (NFLX) Thursday morning and increased its price target to $190 from $166. Netflix gapped open higher Thursday and climbed during the first 45 minutes of trade, before settling into a range. The stock ended the day with a gain...

Aerie Pharmaceuticals Inc. (AERI) announced after the close Wednesday that its Phase 3 study of Roclatan achieved its primary efficacy endpoint. Aerie Pharmaceuticals gapped open dramatically higher Thursday, but pared its gains in the first hour of trade, before settling into a range. Shares still...

Tiffany & Co. (TIF) reported first quarter EPS of $0.74 Wednesday morning, up from $0.69 a year ago. Sales rose 1% to $899.6 million from $891.3 million last year. The consensus estimates were for EPS of $0.70 and revenues of $913.44 million. Tiffany gapped open sharply lower Wednesday, but traded...

Dycom Industries Inc. (DY) reported third quarter EPS of $1.30 Wednesday morning, up from $1.08 a year ago. Analysts expected EPS of $1.19. The company expects to report fourth quarter EPS of $1.35 to $1.50. The consensus estimate is for EPS of $1.79. Dycom gapped open sharply lower Wednesday and...

Neurocrine Biosciences Inc. (NBIX) announced after the bell Tuesday that its Phase II Tourette syndrome T-Force GREEN study of INGREZZA did not meet its primary endpoint. Neurocrine Biosciences gapped open lower Wednesday and declined during the first hour of trade. Shares settled into a range for...

Fidelity & Guaranty Life (FGL) announced Wednesday morning that it has agreed to be acquired by CF Corp. (CFCO) for $31.10 per share in cash. Fidelity & Guaranty Life gapped open sharply higher Wednesday, but moved in a narrow range throughout the session. Shares finished with a gain of 1.90 at $30.60...

Triumph Group Inc. (TGI) reported fourth quarter EPS of $3.09 Wednesday morning, up from $1.32 last year. Street expectations were for EPS of $1.40. Triumph Group gapped open sharply higher Wednesday and climbed in early trade. The stock settled into a range for the majority of the day and closed...

Inovio Pharmaceuticals (INO) announced Wednesday that its HIV vaccine, PENNVAX-GP, produced amongst the highest overall levels of immune response rates ever demonstrated in a human study. Inovio Pharmaceuticals gapped open sharply higher Wednesday, but pared its gains in the first half hour of trade,...

Intuit Inc. (INTU) reported third quarter EPS of $3.90 after the bell Tuesday, up from $3.43 in the previous year. The consensus estimate was for EPS of $3.87. Intuit gapped open sharply higher Wednesday, but traded in a range for the majority of the session. The stock closed higher by 8.68 at $137.83...

Puma Biotechnology Inc. (PBYI) announced Wednesday that the FDA's Oncologic Drugs Advisory Committee voted 12 - 4 to recommend approval of PB272 (neratinib) for the extended adjuvant treatment of HER2-positive early stage breast cancer. Puma Biotechnology was halted for much of Wednesday's session,...

Follow RTT